These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22298169)

  • 1. ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Ndrepepa G; Alger P; Kufner S; Mehilli J; Schömig A; Kastrati A
    Cardiol J; 2012; 19(1):61-9. PubMed ID: 22298169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-hour primary percutaneous coronary angioplasty does not affect outcome of patients with ST-Segment elevation acute myocardial infarction treated within a regional network for reperfusion: The REAL (Registro Regionale Angioplastiche dell'Emilia-Romagna) registry.
    Casella G; Ottani F; Ortolani P; Guastaroba P; Santarelli A; Balducelli M; Menozzi A; Magnavacchi P; Sangiorgi GM; Manari A; De Palma R; Marzocchi A
    JACC Cardiovasc Interv; 2011 Mar; 4(3):270-8. PubMed ID: 21435603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
    Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
    J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the T-peak to T-end interval be a predictor of mortality in patients with ST-elevation myocardial infarction?
    Tatlisu MA; Özcan KS; Güngör B; Ekmekçi A; Çekirdekçi EI; Aruğarslan E; Çinar T; Zengin A; Karaca M; Eren M; Erdinler I
    Coron Artery Dis; 2014 Aug; 25(5):399-404. PubMed ID: 24618985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and predictors of mortality among octogenarians and older with ST-segment elevation myocardial infarction treated with primary coronary angioplasty.
    Caretta G; Passamonti E; Pedroni PN; Fadin BM; Galeazzi GL; Pirelli S
    Clin Cardiol; 2014 Sep; 37(9):523-9. PubMed ID: 25100028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
    Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 24-hr in-hospital interventional cardiology team on timeliness of reperfusion for ST-segment elevation myocardial infarction.
    Allaqaband S; Jan MF; Banday WY; Schlemm A; Ahmed SH; Mori N; Oldridge N; Gupta A; Bajwa T
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):1015-23. PubMed ID: 20517963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
    Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).
    Spitaleri G; Brugaletta S; Scalone G; Moscarella E; Ortega-Paz L; Pernigotti A; Gomez-Lara J; Cequier A; Iñiguez A; Serra A; Jiménez-Quevedo P; Mainar V; Campo G; Tespili M; den Heijer P; Bethencourt A; Vazquez N; Valgimigli M; Serruys PW; Sabaté M
    Am J Cardiol; 2018 May; 121(9):1039-1045. PubMed ID: 29544865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA; Ratib K; Routledge H; Neyses L; Fraser DG; de Belder M; Ludman PF; Nolan J;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):698-706. PubMed ID: 23769648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.
    Claessen BE; van der Schaaf RJ; Verouden NJ; Stegenga NK; Engstrom AE; Sjauw KD; Kikkert WJ; Vis MM; Baan J; Koch KT; de Winter RJ; Tijssen JG; Piek JJ; Henriques JP
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1128-34. PubMed ID: 19926056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of a new multiparametric score for prediction of microvascular obstruction lesions in ST-segment elevation myocardial infarction revascularized by percutaneous coronary intervention.
    Amabile N; Jacquier A; Gaudart J; Sarran A; Shuaib A; Panuel M; Moulin G; Bartoli JM; Paganelli F
    Arch Cardiovasc Dis; 2010 Oct; 103(10):512-21. PubMed ID: 21130964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
    Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
    JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.